CytoSorbents Corporation

Live from GICS 2024 – Day 1! We’re excited to kick off GICS 2024 here in Bengaluru, India! The event has officially begun, and it’s been an incredible day filled with insightful discussions and innovation in critical care. The inaugural ceremony set the tone for what promises to be an inspiring weekend. 🚨 Reminder for tomorrow! 🚨 Join us for an important session on hemoadsorption therapy: 🩺 Session: Personalizing Hemoadsorption in Critical Illness: Navigating Patient Complexity with CytoSorb Therapy 👨⚕️ Speaker: Dr. Yatin Mehta 🗣️ Moderator: Dr. Pradeep Rangappa 📅 Date: October 19, 2024 🕙 Time: 10:00 AM - 10:30 AM IST 📍 Venue: Hall B, Ocean Convention Center And don’t forget to stop by Booth G2 in partnership with Converge Biotech to explore our latest innovations and meet the CytoSorbents team! Stay tuned for more updates! #GICS2024 #CytoSorbents #CriticalCare #Hemoadsorption Converge Biotech

Mark your calendar November 7th,2024 at 4:30pm ET https://lnkd.in/emDNkD5M

🌎 ¡CytoSorbents estará presente en el Congreso ELSO LATAM 2024 en Buenos Aires, Argentina! 🇦🇷 📅 No te pierdas nuestro simposio titulado "Hemoadsorción en ECMO", donde exploraremos el impacto de la respuesta inflamatoria en circuitos extracorpóreos y cómo la hemoadsorción puede modular la hiperinflamación en la terapia ECMO. 🎤 Contaremos con la participación de expertos internacionales: Perf. Alex Muñoz (Colombia): Hablando sobre la modulación de la hiperinflamación en ECMO. Dra. Catalina Corrales (Colombia): Compartiendo su experiencia sobre la hemoadsorción en sepsis, cuando ECMO no es suficiente. 📍 Además, visita nuestro stand compartido con nuestro distribuidor en Argentina. ¡Te esperamos para discutir las últimas innovaciones en cuidados críticos y tecnologías de hemoadsorción! #CytoSorbents #elso_latam #ecmogarrahan #ecmoargentina CARDIOMEDIC S.A.

#DidYouKnow? October 1903: The Birth of Electrocardiography In October 1903, Dutch physiologist Willem Einthoven forever changed the field of medicine with his pioneering invention of the electrocardiograph (#ECG). This breakthrough marked the beginning of modern cardiology and paved the way for the development of non-invasive diagnostic techniques that would become critical in monitoring and diagnosing heart conditions. Before Einthoven’s invention, physicians had limited tools to assess heart function. Although earlier attempts were made to measure the heart’s electrical activity, none were as precise or practical. Einthoven’s solution was his groundbreaking string galvanometer, a device that was much more sensitive than anything before it. It was capable of detecting the faint electrical currents generated by the heart, converting them into visible tracings that doctors could interpret. By meticulously recording these signals, Einthoven was able to identify and classify the different phases of the cardiac cycle, such as the P, Q, R, S, and T waves, which we still recognize on ECGs today. This innovation was the first step in developing modern diagnostic tools for heart diseases, such as arrhythmias, myocardial infarctions, and various forms of cardiac dysfunction. Thanks to Einthoven’s work, medical professionals could now diagnose heart issues that were previously hidden, providing new hope for millions of patients around the world. Willem Einthoven’s contributions did not go unrecognized. In 1924, he was awarded the #NobelPrize in Physiology or Medicine for his discovery of the mechanism of the electrocardiogram, solidifying his legacy as the father of electrocardiography. Although the technology has evolved over the past century, the fundamental principles established by Einthoven remain the foundation of all modern ECG machines. His work continues to save lives to this day. So, next time you see an ECG monitor, remember that it all started in October 1903, with Willem Einthoven’s string galvanometer and a revolutionary vision for cardiac care. #Cardiology #CardiacCare #CytoSorbents #HealthcareHistory #OctoberInHistory

📅 Save the Date: October 23, 2024, 15:00 - 16:00 CET 🔬 Topic: What’s new in the management of severe rhabdomyolysis? 🔍 Gain insights from top-tier experts: • Dr. Frederic Albrecht, Germany: Update on latest scientific data • Prof. Lui Forni, UK: Key messages of the International Consensus Report on hemoadsorption in rhabdomyolysis • Dr. Vedran Premuzič, Croatia: What are the consequences for the daily routine? Whether you're in critical care or nephrology, this webinar will provide valuable, actionable knowledge. Register for free now! https://lnkd.in/exKCv7pk #RhabdomyolysisManagement #MedicalWebinar #CytoSorbents #ClinicalPractice

🌟 Event Highlight: The 38th EACTS Annual Meeting in Lisbon! We had an incredible time at the EACTS Annual Meeting, where CytoSorbents showcased its cutting-edge technologies aimed at improving outcomes in cardiothoracic surgery. One highlight was undoubtedly Prof. Michael Schmoeckels poster presentation on the International Safe and Timely Antithrombotic Removal (STAR) Registry. 🚀 Thank you to everyone who visited our booth and engaged with us on how our innovative solutions are improving patient care. It was a pleasure connecting with so many talented professionals and industry leaders! #EACTS2024 #CardiothoracicSurgery #CytoSorbents #PatientCare #STARRegistry #InnovationInHealthcare

🚨 Mark your calendars! 🚨 CytoSorbents is proud to present at the GICS 2024 Conference from October 18-20, in Bengaluru, India. Join us for a session dedicated to advancing hemoadsorption therapy in critical care: 🩺 Session Title: Personalizing Hemoadsorption in Critical Illness: Navigating Patient Complexity with CytoSorb Therapy 👨⚕️ Speaker: Dr. Yatin Mehta (Gurugram, Haryana, India) 🗣️ Moderator: Dr. Pradeep Rangappa (Bangalore, India) 📅 Date: October 19, 2024 🕙 Time: 10:00 AM - 10:30 AM IST 📍 Venue: Hall B, Ocean Convention Center, Bengaluru, India Plus, stop by Booth G2 in partnership with Converge Biotech for a closer look at our latest innovations and to connect with our expert team! We look forward to seeing you there! #CytoSorb #CriticalCare #Hemoadsorption #GICS2024 #ConvergeBiotech

New in our media center: Hemoadsorption in ACLF patients - What did we learn so far? The recording of the webinar with Prof. Dr. Ali Canbay from Bochum, Germany and Dr. Matthias Schneeweiß-Gleixner from Vienna, Austria is now available in our media center. Watch the recording now or share it with a colleague 👉 https://lnkd.in/eFUXAzjK #MedicalWebinar #Hemoadsorption #ACLF #HealthcareInnovation #LiverDisease

🌟 CytoSorbents auf der 53. Internationalen Jahrestagung der DGfK und der 16. Fokustagung Herz der DGTHG und DGfK 🌟 Wir freuen uns, Sie vom 08. bis 10. November 2024 in Münster zu einem spannenden Austausch über die neuesten Entwicklungen in der Herzmedizin einzuladen. Treffen Sie uns im Messe und Congress Centrum Halle Münsterland und erfahren Sie, wie Sie die CytoSorb Therapie in Ihrem Fachgebiet anwenden können. #DGfK #DGTHG #Herzmedizin #CytoSorbents #MedTech #Herzchirurgie

We are live at the 38th EACTS Annual Meeting in Lisbon! 🇵🇹 CytoSorbents is here to showcase cutting-edge technologies that are enhancing outcomes in cardiothoracic surgery. Come visit us at our booth and learn more about how we are improving patient care with our innovative solutions. Don’t miss this opportunity to connect! #EACTS2024 #CardiothoracicSurgery #CytoSorbents